IOVA
IOVA
NASDAQ · Biotechnology

Iovance Biotherapeutics Inc

$8.04
+0.30 (+3.88%)
As of Nov 7, 1:54 AM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 13 81%
Hold 3 19%
Sell 0 0%
Price Target
Analyst Price Target +581.2% upside
Low Target $41.45
Average Target $54.77
High Target $77.23
Current Price $8.04
Current
$8.04
Target
$54.77
$41.45 $54.77 avg $77.23
Scenario Analysis
Bear Case
$41.45
415.5%
Low target
Base Case
$54.77
+581.2%
Avg target
Bull Case
$77.23
+860.6%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$15.37
-47.7% from high
52-Week Low
$1.76
+356.8% from low
50-Day SMA
$11.38
-29.3% vs SMA
200-Day SMA
$5.98
+34.4% vs SMA
RSI (14)
23.7
Oversold
Target vs 52W High
$54.77
+256.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -40.7%